Papers: 17 Jul 2015 - 24 Jul 2015 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Contribution of the cerebellum to cognitive performance in children and adolescents with multiple sclerosis. Weier K, Till C, Fonov V, Yeh AE, Arnold DL, Banwell B, Collins LD Mult Scler. 2015 Jul 22. PMID: 26203072. Abstract Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis. Hammer LA, Waldner H, Zagon IS, McLaughlin PJ Exp Biol Med (Maywood). 2015 Jul 22. PMID: 26202376. Abstract Biotinidase deficiency mimicking neuromyelitis optica: Initially exhibiting symptoms in adulthood. Bottin L, Prud'hon S, Guey S, Giannesini C, Wolf B, Pindolia K, Stankoff B Mult Scler. 2015 Jul 22. PMID: 26203071. Abstract 'You are just left to get on with it': qualitative study of patient and carer experiences of the transition to secondary progressive multiple sclerosis. Davies F, Edwards A, Brain K, Edwards M, Jones R, Wallbank R, Robertson NP, Wood F BMJ Open. 2015; 5(7):e007674. PMID: 26201723. Abstract Mitochondrial DNA T4216C and A4917G variations in multiple sclerosis. Andalib S, Talebi M, Sakhinia E, Farhoudi M, Sadeghi-Bazargani H, Gjedde A J Neurol Sci. 2015 May 7. PMID: 26201854. Abstract Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability. Turel AP, Oh K, Zagon IS, McLaughlin PJ J Clin Psychopharmacol. 2015 Jul 22. PMID: 26203498. Abstract [Compliance of the guidelines of the Spanish Neurology Society in the treatment of patients with multiple sclerosis]. Oreja-Guevara C, Rio J, Gobartt AL, de En Nombre Del Grupo de Investigadores Del Estudio Futura E N D G I D E F Rev Neurol. 2015 Aug 16; 61(4):145-52. PMID: 26204085. Abstract Effectiveness of Group Versus Individual Yoga Exercises on Fatigue of Patients with Multiple Sclerosis. Karbandi S, Gorji M A H, Mazloum S R, Norian A, Aghaei N N Am J Med Sci. 2015 Jun; 7(6):266-70. PMID: 26199923. Abstract Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination. Makhani N, Banwell B, Tellier R, Yea C, McGovern S, O'Mahony J, Ahorro JM, Arnold D, Sadovnick DA, Marrie RA, et al. Mult Scler. 2015 Jul 21. PMID: 26199356. Abstract Assessment of the Relationship Between Red Cell Distribution Width and Multiple Sclerosis. Peng Y-F, Cao W-Y, Zhang Q, Chen D, Zhang Z-X Medicine (Baltimore). 2015 Jul; 94(29):e1182. PMID: 26200624. Abstract Pathological differences between white and grey matter multiple sclerosis lesions. Prins M, Schul E, Geurts J, van der Valk P, Drukarch B, van Dam A-M Ann N Y Acad Sci. 2015 Jul 22. PMID: 26200258. Abstract Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells. Leikfoss IS, Keshari PK, Gustavsen MW, Bjølgerud A, Brorson IS, Celius EG, Spurkland A, Bos SD, Harbo HF, Berge T PLoS One. 2015; 10(7):e0132957. Epub 2015 Jul 23. PMID: 26203907. Abstract Increased multiple sclerosis relapses related to lower prevalence of pain. da Silva J V M, de Oliveira B F A, do Nascimento O J M, Farinhas J G D, Cavaliere M G, de Cal H RSá, da Matta A P C Arq Neuropsiquiatr. 2015 Jul; 73(7):593-600. PMID: 26200054. Abstract Robot-supported upper limb training in a virtual learning environment : a pilot randomized controlled trial in persons with MS. Feys P, Coninx K, Kerkhofs L, De Weyer T, Truyens V, Maris A, Lamers I J Neuroeng Rehabil. 2015; 12(1):60. Epub 2015 Jul 23. PMID: 26202325. Abstract Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail. Van Schependom J, Gielen J, Laton J, Nagels G Mult Scler. 2015 Jul 21. PMID: 26199353. Abstract Diffusion tensor magnetic resonance imaging in very early onset pediatric multiple sclerosis. Rocca MA, Sonkin M, Copetti M, Pagani E, Arnold DL, Narayanan S, Sled JG, Banwell B, Filippi M Mult Scler. 2015 Jul 21. PMID: 26199355. Abstract Intractable cough as characteristic symptom of neuromyelitis optica and neuromyelitis optica spectrum disorder. Fujita-Nakata M, Tomioka R, Tanaka K, Nakanishi M, Nagayama S, Takahashi R, Machiya T, Hamada T, Matsui M Mult Scler. 2015 Jul 21. PMID: 26199354. Abstract Corrigendum to "Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis" [Mult. Scler. Relat. Disord. 4 (2015) 104-111]. Racosta J M, Sposato LA, Morrow SA, Cipriano L, Kimpinski K, Kremenchutzky M Mult Scler Relat Disord. 2015 Jul; 4(4):385. PMID: 26195062. Abstract Why some of us do not like the expression "no evidence of disease activity" (NEDA) in multiple sclerosis. Fragoso Y D Mult Scler Relat Disord. 2015 Jul; 4(4):383-4. PMID: 26195061. Abstract Symptoms of multiple sclerosis during use of combined hormonal contraception. Kempe P, Hammar M, Brynhildsen J Eur J Obstet Gynecol Reprod Biol. 2015 Jul 9; 193:1-4. PMID: 26196655. Abstract Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients. Basnyat P, Hagman S, Kolasa M, Koivisto K, Verkkoniemi-Ahola A, Airas L, Elovaara I Mult Scler Relat Disord. 2015 Jul; 4(4):334-8. PMID: 26195052. Abstract Effectiveness of telerehabilitation interventions in persons with multiple sclerosis: A systematic review. Amatya B, Galea MP, Kesselring J, Khan F Mult Scler Relat Disord. 2015 Jul; 4(4):358-69. PMID: 26195057. Abstract Specificity and sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: A meta-analysis. Ruiz-Gaviria R, Baracaldo I, Castañeda C, Ruiz-Patiño A, Acosta-Hernandez A, Rosselli D Mult Scler Relat Disord. 2015 Jul; 4(4):345-9. PMID: 26195055. Abstract Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosis. Newsome SD, Guo S, Altincatal A, Proskorovsky I, Kinter E, Phillips G, You X, Sabatella G Mult Scler Relat Disord. 2015 Jul; 4(4):350-7. PMID: 26195056. Abstract Muscular dystrophy in a patient with multiple sclerosis. Another "double-trouble"? Parissis D, Ioannidis P, Bakirtzis C, Grigoriadis N, Karacostas D Mult Scler Relat Disord. 2015 Jul; 4(4):342-4. PMID: 26195054. Abstract Natalizumab is effective in controlling the inflammatory rebound after its discontinuation and failure of an alternative treatment. Barroso B, Miquel M, Marasescu R, Demasles S, Krim E, Bonnan M Mult Scler Relat Disord. 2015 Jul; 4(4):380-2. PMID: 26195060. Abstract The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk. Khatri BO, Garland J, Berger J, Kramer J, Sershon L, Olapo T, Sesing J, Dukic M, Rehn E Mult Scler Relat Disord. 2015 Jul; 4(4):377-9. PMID: 26195059. Abstract GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40mg three-times weekly versus 20mg daily in patients with relapsing-remitting multiple sclerosis. Wolinsky JS, Borresen ET, Dietrich DW, Wynn D, Sidi Y, Steinerman JR, Knappertz V, Kolodny S, GLACIER Study Group Mult Scler Relat Disord. 2015 Jul; 4(4):370-6. PMID: 26195058. Abstract Effects of dimethyl fumarate on lymphocyte subsets. Berkovich R, Weiner LP Mult Scler Relat Disord. 2015 Jul; 4(4):339-41. PMID: 26195053. Abstract Post-operative quadriplegia as the initial manifestation of tumefactive multiple sclerosis. Maghsoudi B, Haddad H, Vatankhah P, Rasekhi A, Jaberi A R Indian J Crit Care Med. 2015 Jun; 19(6):359-61. PMID: 26195864. Abstract B Cells and Autoantibodies in Multiple Sclerosis. Pröbstel A-K, Sanderson N S, Derfuss T Int J Mol Sci. 2015; 16(7):16576-92. PMID: 26197319. Abstract Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis). Veauthier C, Gaede G, Radbruch H, Wernecke K-D, Paul F Int J Mol Sci. 2015; 16(7):16514-28. PMID: 26197315. Abstract Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis. Harrison DM, Roy S, Oh J, Izbudak I, Pham D, Courtney S, Caffo B, Jones CK, van Zijl P, Calabresi PA JAMA Neurol. 2015 Jul 20. PMID: 26192316. Abstract Considerations on the appropriateness of the John Cunningham virus antibody assay use in patients with rheumatoid arthritis. Borie D, Kremer JM Semin Arthritis Rheum. 2015 Jun 17. PMID: 26190565. Abstract Cortical Lesions in Multiple Sclerosis: Clinical Relevance for a Hidden Disease Burden. Naismith RT JAMA Neurol. 2015 Jul 20. PMID: 26191784. Abstract Optical coherence tomography reflects brain atrophy in MS: A four year study. Saidha S, Al-Louzi O, Ratchford JN, Bhargava P, Oh J, Newsome SD, Prince JL, Pham D, Roy S, van Zijl P, et al. Ann Neurol. 2015 Jul 18. PMID: 26190464. Abstract Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients. Arru G, Caggiu E, Leoni S, Mameli G, Pugliatti M, Sechi G P, Sechi LA J Neurol Sci. 2015 Jul 8. PMID: 26190523. Abstract A pain-mediated neural signal induces relapse in murine autoimmune encephalomyelitis, a multiple sclerosis model. Arima Y, Kamimura D, Atsumi T, Harada M, Kawamoto T, Nishikawa N, Stofkova A, Ohki T, Higuchi K, Morimoto Y, et al. Elife. 2015 Jul 20; 4. PMID: 26193120. Abstract Illness perception, treatment beliefs, self-esteem, and self-efficacy as correlates of self-management in multiple sclerosis. Wilski M, Tasiemski T Acta Neurol Scand. 2015 Jul 20. PMID: 26190764. Abstract Beyond Depression: Predictors of Self-Reported Cognitive Function in Adults Living With MS. Beier M, Amtmann D, Ehde DM Rehabil Psychol. 2015 Jul 20. PMID: 26192051. Abstract Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli? Spampinato SF, Obermeier B, Cotleur A, Love A, Takeshita Y, Sano Y, Kanda T, Ransohoff RM PLoS One. 2015; 10(7):e0133392. Epub 2015 Jul 21. PMID: 26197437. Abstract Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families. Kuo C-F, Grainge MJ, Valdes AM, See L-C, Luo S-F, Yu K-H, Zhang W, Doherty M JAMA Intern Med. 2015 Jul 20. PMID: 26193127. Abstract Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells. Trinschek B, Luessi F, Gross CC, Wiendl H, Jonuleit H Int J Mol Sci. 2015; 16(7):16330-46. PMID: 26193267. Abstract [Immunotherapy and infectious issues in multiple sclerosis : Self-injectable and oral drugs for immunotherapy]. Winkelmann A, Löbermann M, Reisinger E, Hartung H-P, Zettl UK Nervenarzt. 2015 Jul 19. PMID: 26187544. Abstract Diagnostic tools for evaluating the impact of Focal Axonal Swellings arising in neurodegenerative diseases and/or traumatic brain injury. Maia PD, Hemphill MA, Zehnder B, Zhang C, Parker KK, Kutz NJ J Neurosci Methods. 2015 Jul 16; 253:233-243. PMID: 26188255. Abstract [Infection risks in multiple sclerosis therapy by infusion of disease modifying drugs]. Winkelmann A, Löbermann M, Reisinger E, Hartung H-P, Zettl UK Nervenarzt. 2015 Jul 19. PMID: 26187545. Abstract Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis. Cramer SP, Modvig S, Simonsen HJ, Frederiksen JL, Larsson HBW Brain. 2015 Jul 17. PMID: 26187333. Abstract Effect of ether glycerol lipids on interleukin-1β release and experimental autoimmune encephalomyelitis. Boomkamp SD, Byun H-S, Ubhi S, Jiang H-R, Pyne S, Bittman R, Pyne NJ Chem Phys Lipids. 2015 Jul 14. PMID: 26187854. Abstract Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis. PLOS ONE Staff PLoS One. 2015; 10(7):e0131260. PMID: 26186539. Abstract Haplotype-based approach to known MS-associated regions increases the amount of explained risk. Khankhanian P, Gourraud P-A, Lizee A, Goodin DS J Med Genet. 2015 Jul 16. PMID: 26185143. Abstract Serum complement factor and Tyr4O2 His gene polymorphism among Egyptians with multiple sclerosis. Abdel Rasol HA, Helmy H, Aziz MA Neurol Res. 2015 Jul 17:1743132815Y0000000075. PMID: 26186240. Abstract The Perspectives of Mesenchymal Stem Cell Therapy in the Treatment of Multiple Sclerosis. Naderi N Iran J Pharm Res. 2015 Winter; 14(Suppl):1-2. PMID: 26185500. Abstract Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration. Bozin I, Ge Y, Kuchling J, Dusek P, Chawla S, Harms L, Ruprecht K, Niendorf T, Paul F, Kister I, et al. PLoS One. 2015; 10(7):e0128386. Epub 2015 Jul 17. PMID: 26186349. Abstract A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis. Gu BJ, Field J, Dutertre S, Ou A, Kilpatrick TJ, Lechner-Scott J, Scott R, Lea R, Taylor BV, Stankovich J, et al. Hum Mol Genet. 2015 Jul 17. Epub 2015 Jul 17. PMID: 26188005. Abstract Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction. Esposito F, Guaschino C, Sorosina M, Clarelli F, Ferre' L, Mascia E, Santoro S, Pagnesi M, Radaelli M, Colombo B, et al. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e129. Epub 2015 Jul 09. PMID: 26185776. Abstract Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b. Weller I, Saake A, Schreiner T, Vogelreuter J, Petroff N Patient Prefer Adherence. 2015; 9:951-9. Epub 2015 Jul 07. PMID: 26185425. Abstract Brain Plasticity Effects of Neuromodulation Against Multiple Sclerosis Fatigue. Tecchio F, Cancelli A, Cottone C, Ferrucci R, Vergari M, Zito G, Pasqualetti P, Filippi M M, Ghazaryan A, Lupoi D, et al. Front Neurol. 2015; 6:141. Epub 2015 Jul 03. PMID: 26191036. Abstract Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models. Chua AS, Egorova S, Anderson MC, Polgar-Turcsanyi M, Chitnis T, Weiner HL, Guttmann CRG, Bakshi R, Healy BC Neuroimage Clin. 2015; 8:606-10. Epub 2015 Jul 02. PMID: 26199872. Abstract Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis. Chalmoukou K, Alexopoulos H, Akrivou S, Stathopoulos P, Reindl M, Dalakas MC Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e131. Epub 2015 Jul 02. PMID: 26185777. Abstract Predictive value of early brain atrophy on response in patients treated with interferon β. Pérez-Miralles F C, Sastre-Garriga J, Vidal-Jordana A, Río J, Auger C, Pareto D, Tintoré M, Rovira A, Montalban X Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e132. Epub 2015 Jul 02. PMID: 26185778. Abstract Aquaporin-4 autoimmunity. Zekeridou A, Lennon VA Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e110. Epub 2015 May 21. PMID: 26185772. Abstract Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis. Constantinescu CS, Asher A, Fryze W, Kozubski W, Wagner F, Aram J, Tanasescu R, Korolkiewicz RP, Dirnberger-Hertweck M, Steidl S, et al. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e117. Epub 2015 May 21. PMID: 26185773. Abstract Research Findings on Overactive Bladder. Patra PB, Patra S Curr Urol. 2015 May; 8(1):1-21. Epub 2015 May 20. PMID: 26195957. Abstract [Pulmonary lymphangioleiomyomatosis of unusual revelation during multiple sclerosis]. Jaafoura N G, Guigua A, Zaghouani H, Atig A, Bakir D, Khalifa M, Bahri F Pan Afr Med J. 2015; 20:398. Epub 2015 Apr 23. PMID: 26185588. Abstract
Contribution of the cerebellum to cognitive performance in children and adolescents with multiple sclerosis. Weier K, Till C, Fonov V, Yeh AE, Arnold DL, Banwell B, Collins LD Mult Scler. 2015 Jul 22. PMID: 26203072. Abstract
Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis. Hammer LA, Waldner H, Zagon IS, McLaughlin PJ Exp Biol Med (Maywood). 2015 Jul 22. PMID: 26202376. Abstract
Biotinidase deficiency mimicking neuromyelitis optica: Initially exhibiting symptoms in adulthood. Bottin L, Prud'hon S, Guey S, Giannesini C, Wolf B, Pindolia K, Stankoff B Mult Scler. 2015 Jul 22. PMID: 26203071. Abstract
'You are just left to get on with it': qualitative study of patient and carer experiences of the transition to secondary progressive multiple sclerosis. Davies F, Edwards A, Brain K, Edwards M, Jones R, Wallbank R, Robertson NP, Wood F BMJ Open. 2015; 5(7):e007674. PMID: 26201723. Abstract
Mitochondrial DNA T4216C and A4917G variations in multiple sclerosis. Andalib S, Talebi M, Sakhinia E, Farhoudi M, Sadeghi-Bazargani H, Gjedde A J Neurol Sci. 2015 May 7. PMID: 26201854. Abstract
Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability. Turel AP, Oh K, Zagon IS, McLaughlin PJ J Clin Psychopharmacol. 2015 Jul 22. PMID: 26203498. Abstract
[Compliance of the guidelines of the Spanish Neurology Society in the treatment of patients with multiple sclerosis]. Oreja-Guevara C, Rio J, Gobartt AL, de En Nombre Del Grupo de Investigadores Del Estudio Futura E N D G I D E F Rev Neurol. 2015 Aug 16; 61(4):145-52. PMID: 26204085. Abstract
Effectiveness of Group Versus Individual Yoga Exercises on Fatigue of Patients with Multiple Sclerosis. Karbandi S, Gorji M A H, Mazloum S R, Norian A, Aghaei N N Am J Med Sci. 2015 Jun; 7(6):266-70. PMID: 26199923. Abstract
Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination. Makhani N, Banwell B, Tellier R, Yea C, McGovern S, O'Mahony J, Ahorro JM, Arnold D, Sadovnick DA, Marrie RA, et al. Mult Scler. 2015 Jul 21. PMID: 26199356. Abstract
Assessment of the Relationship Between Red Cell Distribution Width and Multiple Sclerosis. Peng Y-F, Cao W-Y, Zhang Q, Chen D, Zhang Z-X Medicine (Baltimore). 2015 Jul; 94(29):e1182. PMID: 26200624. Abstract
Pathological differences between white and grey matter multiple sclerosis lesions. Prins M, Schul E, Geurts J, van der Valk P, Drukarch B, van Dam A-M Ann N Y Acad Sci. 2015 Jul 22. PMID: 26200258. Abstract
Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells. Leikfoss IS, Keshari PK, Gustavsen MW, Bjølgerud A, Brorson IS, Celius EG, Spurkland A, Bos SD, Harbo HF, Berge T PLoS One. 2015; 10(7):e0132957. Epub 2015 Jul 23. PMID: 26203907. Abstract
Increased multiple sclerosis relapses related to lower prevalence of pain. da Silva J V M, de Oliveira B F A, do Nascimento O J M, Farinhas J G D, Cavaliere M G, de Cal H RSá, da Matta A P C Arq Neuropsiquiatr. 2015 Jul; 73(7):593-600. PMID: 26200054. Abstract
Robot-supported upper limb training in a virtual learning environment : a pilot randomized controlled trial in persons with MS. Feys P, Coninx K, Kerkhofs L, De Weyer T, Truyens V, Maris A, Lamers I J Neuroeng Rehabil. 2015; 12(1):60. Epub 2015 Jul 23. PMID: 26202325. Abstract
Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail. Van Schependom J, Gielen J, Laton J, Nagels G Mult Scler. 2015 Jul 21. PMID: 26199353. Abstract
Diffusion tensor magnetic resonance imaging in very early onset pediatric multiple sclerosis. Rocca MA, Sonkin M, Copetti M, Pagani E, Arnold DL, Narayanan S, Sled JG, Banwell B, Filippi M Mult Scler. 2015 Jul 21. PMID: 26199355. Abstract
Intractable cough as characteristic symptom of neuromyelitis optica and neuromyelitis optica spectrum disorder. Fujita-Nakata M, Tomioka R, Tanaka K, Nakanishi M, Nagayama S, Takahashi R, Machiya T, Hamada T, Matsui M Mult Scler. 2015 Jul 21. PMID: 26199354. Abstract
Corrigendum to "Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis" [Mult. Scler. Relat. Disord. 4 (2015) 104-111]. Racosta J M, Sposato LA, Morrow SA, Cipriano L, Kimpinski K, Kremenchutzky M Mult Scler Relat Disord. 2015 Jul; 4(4):385. PMID: 26195062. Abstract
Why some of us do not like the expression "no evidence of disease activity" (NEDA) in multiple sclerosis. Fragoso Y D Mult Scler Relat Disord. 2015 Jul; 4(4):383-4. PMID: 26195061. Abstract
Symptoms of multiple sclerosis during use of combined hormonal contraception. Kempe P, Hammar M, Brynhildsen J Eur J Obstet Gynecol Reprod Biol. 2015 Jul 9; 193:1-4. PMID: 26196655. Abstract
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients. Basnyat P, Hagman S, Kolasa M, Koivisto K, Verkkoniemi-Ahola A, Airas L, Elovaara I Mult Scler Relat Disord. 2015 Jul; 4(4):334-8. PMID: 26195052. Abstract
Effectiveness of telerehabilitation interventions in persons with multiple sclerosis: A systematic review. Amatya B, Galea MP, Kesselring J, Khan F Mult Scler Relat Disord. 2015 Jul; 4(4):358-69. PMID: 26195057. Abstract
Specificity and sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: A meta-analysis. Ruiz-Gaviria R, Baracaldo I, Castañeda C, Ruiz-Patiño A, Acosta-Hernandez A, Rosselli D Mult Scler Relat Disord. 2015 Jul; 4(4):345-9. PMID: 26195055. Abstract
Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosis. Newsome SD, Guo S, Altincatal A, Proskorovsky I, Kinter E, Phillips G, You X, Sabatella G Mult Scler Relat Disord. 2015 Jul; 4(4):350-7. PMID: 26195056. Abstract
Muscular dystrophy in a patient with multiple sclerosis. Another "double-trouble"? Parissis D, Ioannidis P, Bakirtzis C, Grigoriadis N, Karacostas D Mult Scler Relat Disord. 2015 Jul; 4(4):342-4. PMID: 26195054. Abstract
Natalizumab is effective in controlling the inflammatory rebound after its discontinuation and failure of an alternative treatment. Barroso B, Miquel M, Marasescu R, Demasles S, Krim E, Bonnan M Mult Scler Relat Disord. 2015 Jul; 4(4):380-2. PMID: 26195060. Abstract
The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk. Khatri BO, Garland J, Berger J, Kramer J, Sershon L, Olapo T, Sesing J, Dukic M, Rehn E Mult Scler Relat Disord. 2015 Jul; 4(4):377-9. PMID: 26195059. Abstract
GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40mg three-times weekly versus 20mg daily in patients with relapsing-remitting multiple sclerosis. Wolinsky JS, Borresen ET, Dietrich DW, Wynn D, Sidi Y, Steinerman JR, Knappertz V, Kolodny S, GLACIER Study Group Mult Scler Relat Disord. 2015 Jul; 4(4):370-6. PMID: 26195058. Abstract
Effects of dimethyl fumarate on lymphocyte subsets. Berkovich R, Weiner LP Mult Scler Relat Disord. 2015 Jul; 4(4):339-41. PMID: 26195053. Abstract
Post-operative quadriplegia as the initial manifestation of tumefactive multiple sclerosis. Maghsoudi B, Haddad H, Vatankhah P, Rasekhi A, Jaberi A R Indian J Crit Care Med. 2015 Jun; 19(6):359-61. PMID: 26195864. Abstract
B Cells and Autoantibodies in Multiple Sclerosis. Pröbstel A-K, Sanderson N S, Derfuss T Int J Mol Sci. 2015; 16(7):16576-92. PMID: 26197319. Abstract
Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis). Veauthier C, Gaede G, Radbruch H, Wernecke K-D, Paul F Int J Mol Sci. 2015; 16(7):16514-28. PMID: 26197315. Abstract
Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis. Harrison DM, Roy S, Oh J, Izbudak I, Pham D, Courtney S, Caffo B, Jones CK, van Zijl P, Calabresi PA JAMA Neurol. 2015 Jul 20. PMID: 26192316. Abstract
Considerations on the appropriateness of the John Cunningham virus antibody assay use in patients with rheumatoid arthritis. Borie D, Kremer JM Semin Arthritis Rheum. 2015 Jun 17. PMID: 26190565. Abstract
Cortical Lesions in Multiple Sclerosis: Clinical Relevance for a Hidden Disease Burden. Naismith RT JAMA Neurol. 2015 Jul 20. PMID: 26191784. Abstract
Optical coherence tomography reflects brain atrophy in MS: A four year study. Saidha S, Al-Louzi O, Ratchford JN, Bhargava P, Oh J, Newsome SD, Prince JL, Pham D, Roy S, van Zijl P, et al. Ann Neurol. 2015 Jul 18. PMID: 26190464. Abstract
Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients. Arru G, Caggiu E, Leoni S, Mameli G, Pugliatti M, Sechi G P, Sechi LA J Neurol Sci. 2015 Jul 8. PMID: 26190523. Abstract
A pain-mediated neural signal induces relapse in murine autoimmune encephalomyelitis, a multiple sclerosis model. Arima Y, Kamimura D, Atsumi T, Harada M, Kawamoto T, Nishikawa N, Stofkova A, Ohki T, Higuchi K, Morimoto Y, et al. Elife. 2015 Jul 20; 4. PMID: 26193120. Abstract
Illness perception, treatment beliefs, self-esteem, and self-efficacy as correlates of self-management in multiple sclerosis. Wilski M, Tasiemski T Acta Neurol Scand. 2015 Jul 20. PMID: 26190764. Abstract
Beyond Depression: Predictors of Self-Reported Cognitive Function in Adults Living With MS. Beier M, Amtmann D, Ehde DM Rehabil Psychol. 2015 Jul 20. PMID: 26192051. Abstract
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli? Spampinato SF, Obermeier B, Cotleur A, Love A, Takeshita Y, Sano Y, Kanda T, Ransohoff RM PLoS One. 2015; 10(7):e0133392. Epub 2015 Jul 21. PMID: 26197437. Abstract
Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families. Kuo C-F, Grainge MJ, Valdes AM, See L-C, Luo S-F, Yu K-H, Zhang W, Doherty M JAMA Intern Med. 2015 Jul 20. PMID: 26193127. Abstract
Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells. Trinschek B, Luessi F, Gross CC, Wiendl H, Jonuleit H Int J Mol Sci. 2015; 16(7):16330-46. PMID: 26193267. Abstract
[Immunotherapy and infectious issues in multiple sclerosis : Self-injectable and oral drugs for immunotherapy]. Winkelmann A, Löbermann M, Reisinger E, Hartung H-P, Zettl UK Nervenarzt. 2015 Jul 19. PMID: 26187544. Abstract
Diagnostic tools for evaluating the impact of Focal Axonal Swellings arising in neurodegenerative diseases and/or traumatic brain injury. Maia PD, Hemphill MA, Zehnder B, Zhang C, Parker KK, Kutz NJ J Neurosci Methods. 2015 Jul 16; 253:233-243. PMID: 26188255. Abstract
[Infection risks in multiple sclerosis therapy by infusion of disease modifying drugs]. Winkelmann A, Löbermann M, Reisinger E, Hartung H-P, Zettl UK Nervenarzt. 2015 Jul 19. PMID: 26187545. Abstract
Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis. Cramer SP, Modvig S, Simonsen HJ, Frederiksen JL, Larsson HBW Brain. 2015 Jul 17. PMID: 26187333. Abstract
Effect of ether glycerol lipids on interleukin-1β release and experimental autoimmune encephalomyelitis. Boomkamp SD, Byun H-S, Ubhi S, Jiang H-R, Pyne S, Bittman R, Pyne NJ Chem Phys Lipids. 2015 Jul 14. PMID: 26187854. Abstract
Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis. PLOS ONE Staff PLoS One. 2015; 10(7):e0131260. PMID: 26186539. Abstract
Haplotype-based approach to known MS-associated regions increases the amount of explained risk. Khankhanian P, Gourraud P-A, Lizee A, Goodin DS J Med Genet. 2015 Jul 16. PMID: 26185143. Abstract
Serum complement factor and Tyr4O2 His gene polymorphism among Egyptians with multiple sclerosis. Abdel Rasol HA, Helmy H, Aziz MA Neurol Res. 2015 Jul 17:1743132815Y0000000075. PMID: 26186240. Abstract
The Perspectives of Mesenchymal Stem Cell Therapy in the Treatment of Multiple Sclerosis. Naderi N Iran J Pharm Res. 2015 Winter; 14(Suppl):1-2. PMID: 26185500. Abstract
Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration. Bozin I, Ge Y, Kuchling J, Dusek P, Chawla S, Harms L, Ruprecht K, Niendorf T, Paul F, Kister I, et al. PLoS One. 2015; 10(7):e0128386. Epub 2015 Jul 17. PMID: 26186349. Abstract
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis. Gu BJ, Field J, Dutertre S, Ou A, Kilpatrick TJ, Lechner-Scott J, Scott R, Lea R, Taylor BV, Stankovich J, et al. Hum Mol Genet. 2015 Jul 17. Epub 2015 Jul 17. PMID: 26188005. Abstract
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction. Esposito F, Guaschino C, Sorosina M, Clarelli F, Ferre' L, Mascia E, Santoro S, Pagnesi M, Radaelli M, Colombo B, et al. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e129. Epub 2015 Jul 09. PMID: 26185776. Abstract
Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b. Weller I, Saake A, Schreiner T, Vogelreuter J, Petroff N Patient Prefer Adherence. 2015; 9:951-9. Epub 2015 Jul 07. PMID: 26185425. Abstract
Brain Plasticity Effects of Neuromodulation Against Multiple Sclerosis Fatigue. Tecchio F, Cancelli A, Cottone C, Ferrucci R, Vergari M, Zito G, Pasqualetti P, Filippi M M, Ghazaryan A, Lupoi D, et al. Front Neurol. 2015; 6:141. Epub 2015 Jul 03. PMID: 26191036. Abstract
Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models. Chua AS, Egorova S, Anderson MC, Polgar-Turcsanyi M, Chitnis T, Weiner HL, Guttmann CRG, Bakshi R, Healy BC Neuroimage Clin. 2015; 8:606-10. Epub 2015 Jul 02. PMID: 26199872. Abstract
Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis. Chalmoukou K, Alexopoulos H, Akrivou S, Stathopoulos P, Reindl M, Dalakas MC Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e131. Epub 2015 Jul 02. PMID: 26185777. Abstract
Predictive value of early brain atrophy on response in patients treated with interferon β. Pérez-Miralles F C, Sastre-Garriga J, Vidal-Jordana A, Río J, Auger C, Pareto D, Tintoré M, Rovira A, Montalban X Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e132. Epub 2015 Jul 02. PMID: 26185778. Abstract
Aquaporin-4 autoimmunity. Zekeridou A, Lennon VA Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e110. Epub 2015 May 21. PMID: 26185772. Abstract
Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis. Constantinescu CS, Asher A, Fryze W, Kozubski W, Wagner F, Aram J, Tanasescu R, Korolkiewicz RP, Dirnberger-Hertweck M, Steidl S, et al. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e117. Epub 2015 May 21. PMID: 26185773. Abstract
Research Findings on Overactive Bladder. Patra PB, Patra S Curr Urol. 2015 May; 8(1):1-21. Epub 2015 May 20. PMID: 26195957. Abstract
[Pulmonary lymphangioleiomyomatosis of unusual revelation during multiple sclerosis]. Jaafoura N G, Guigua A, Zaghouani H, Atig A, Bakir D, Khalifa M, Bahri F Pan Afr Med J. 2015; 20:398. Epub 2015 Apr 23. PMID: 26185588. Abstract